News Search: all ClickPress    just this category More search options

 
Home : Science : Page 3
News Releases:
  Pages: [<<] 1 2 3 4 5 6 7 8 9 [>>]
  • MediCortex USA, Ltd. to present at the 8th annual BIO-Europe Spring conference, March 10-12, Turin,
    Dr. Adrian Harel, MediCortex’s founder and CEO, stated: “At this year's conference, me and Dr. Ari Massoudi will present the development plan of our new drug candidates, which are aimed at moderating the effects of TBI. The company has designed three chemically verified proprietary NCE’s, each with properties for crossing the brain-blood-barrier, and possessing at least two neuroprotective functions, such as free metal ion binding, anti-oxidation, anti-inflammation, and/or anti-bacterial activity.”
    Company: Medicortex USA Ltd.
    (Filed: Fri Feb 28 2014)
  • Ness-Ziona, Israel December 4th , 2013 — Medicortex USA Ltd. CEO will participate in the 22nd ISFN
    Traumatic Brain Injury (TBI) is a frequent neurological condition, representing a worldwide economic burden with rapidly growing incidence. TBI is difficult to diagnose because of the many different performances in each individual following the initial trauma and subsequent late stage clinical signs, which appear following the primary TBI incident. TBI involves the injured patient, his/her immediate family, the social environment, as well as the health facilities and social services. In addition, as yet no drug is available to address the progression of the secondary injury to the brain upon TBI.
    Company: Medicortex USA Ltd.
    (Filed: Tue Dec 03 2013)
  • Medicortex USA Ltd. CEO to present at The 2nd TBI-Challenge.eu 2013
    Medicortex USA Ltd. CEO to present at The 2nd TBI-Challenge.eu 2013 BIENNIAL INTERDISCIPLINARY CONFERENCE of the BRAIN INJURY AND FAMILIES / EUROPEAN FEDERATION (BIF) on September 19-21, 2013 at the University of Vienna, Austria
    Company: Medicortex USA Ltd.
    (Filed: Tue Sep 17 2013)
  • BREAKTHROUGH: Technology invented to create energy from nothing by harnessing zero point energy.
    Priza Technologies Inc, a small Silicon Valley company has been able to create method and technology to harness zero point energy. This means that they can create energy without any fuel, from nothing. They are running a crowd funding campaign to raise funds to take this technology to the market at: http://www.indiegogo.com/projects/z-point-energy-biggest- discovery-of-science
    Company: Priza Technologies Inc
    (Filed: Fri Sep 13 2013)
  • Medicortex USA Ltd. attending the 2nd TBI-Challenge.eu 2013
    Medicortex USA Ltd. announced today that the company has been invited to attend the 2nd TBI-Challenge.eu 2013 BIENNIAL INTERDISCIPLINARY CONFERENCE of the BRAIN INJURY AND FAMILIES / EUROPEAN FEDERATION (BIF) on September 19-21, 2013 at the University of Vienna, Austria.
    Company: Medicortex USA Ltd.
    (Filed: Sat Aug 31 2013)
  • Xcelience expands dry granulation expertise in GMP Manufacturing
    Xcelience, a leader in early drug development, has expanded its solid oral dosage form development and manufacturing capabilities to include a Vector TFC-220 Roller Compactor in the GMP Manufacturing area. The addition of this new equipment enables clients to achieve a faster transition from development in the experimental area to GMP production of clinical supplies.
    Company: Xcelience, LLC
    (Filed: Tue Sep 28 2010)
  • Women & Infants Receives $2 Million Grant from NIH to Continue Work on Perinatal Biology
    Women & Infants Hospital has recently received a $2.1 million grant from the National Institutes of Health (NIH) to continue work under the Center of Biomedical Research Excellence (COBRE) for Perinatal Biology. Of the 108 COBREs across the country, Women & Infants is the only one specifically focused on developmental research.
    Company: Women & Infants Hospital
    (Filed: Mon Sep 27 2010)
  • French biotech marches on into 21st century
    The International BIO 2010 convention, held recently in Chicago, was a chance to promote French expertise and strengths in the biotechnology sector. The importance of the industry cannot be underestimated: almost half of all new drugs on the world market have their origins in biotechnologies. Outside healthcare, nano-biotechnologies – a cross between biotechnologies and ICT – and biotechnologies for environmental purposes are particularly promising research areas. In March next year, the French city of Nantes will host the Biomarine 2011 summit, which will be devoted to marine biotechnologies, or ‘blue biotechnologies’.
    Company: Press Office of the French Trade Commission
    (Filed: Tue Jun 08 2010)
  • The Worlds Biggest Yacht
    Russian billionaire finally reveals the world's biggest yacht.
    Company: YouMe Support Foundation & Child Trust Fund with Win a Resort
    (Filed: Wed Apr 28 2010)
  • Coats That Create Invisibility
    The invisible cloak is not just science fiction, it could one day be a reality.
    Company: YouMe Support Foundation & Child Trust Fund with Win a Resort
    (Filed: Wed Apr 21 2010)
  Pages: [<<] 1 2 3 4 5 6 7 8 9 [>>]
 

Home - Latest News - Submit News - Advanced Search - About Us - Contact Us - News Alerts Subscribe/Unsubscribe | RSS
©2005-2017 ClickPress - Terms & Conditions

ClickPress is a SpecialNoise business service